I-Mab stock price target raised to $9 from $7 at BTIG on strategic shift
PositiveFinancial Markets

I-Mab's stock price target has been raised from $7 to $9 by BTIG, reflecting a positive strategic shift within the company. This adjustment indicates growing confidence in I-Mab's future prospects and could attract more investors, highlighting the company's potential for growth in the biopharmaceutical sector.
— Curated by the World Pulse Now AI Editorial System